
WELL Health reported a quarterly loss of C$0.50 per share, well above the estimated loss of C$0.04. Revenue and adjusted EBITDA in Canadian Patient Services offered a more positive view of operations.
WELL Health Technologies Corp. (TSX: WELL) released results after market close on November 8 for the quarter ended September 30, 2026. Calendar data shows earnings per share (EPS) of -C$0.50, compared with an estimated -C$0.04—a miss of 1,150%. The company reported revenue of C$407.4 million and an 82% increase in Canadian Patient Services adjusted EBITDA, to C$25.7 million. WELL also reported a quarterly net loss of C$128.4 million and reaffirmed its 2026 adjusted EBITDA guidance of C$185 million to C$195 million. Visit the WELL stock page for more company and share information.
Recent earnings trend
WELL Health Technologies Corp
WELL.TO
WELL.TO
WELL Health Technologies Corp
Market cap
$985.39M
52W high
$5.19
52W low
$3.54
1W change
+1.67%
Beta
1.24
Analyst Price Targets
Based on analyst covering WELL · as of Nov 16, 2026
Wall Street analysts forecast WELL stock price to rise 97.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.21
+97.6% Upside
Previously C$7.25 on Nov 11, 2026
Current Price
C$3.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WELL's historical volatility
30-Day Vol
55.8%
Annualized
90-Day Vol
43.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.44 | C$2.84 – C$4.17 |
| 60 trading days | C$3.24 | C$2.47 – C$4.25 |
| 90 trading days | C$3.05 | C$2.19 – C$4.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 8 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-12-31 | 2027-03-18 | — | 0.0900 | — |
| 2026-09-30 | 2026-11-08 | -0.5000 | -0.0400 | -1150.0% |
| 2026-06-30 | 2026-08-06 | 0.0400 | 0.0600 | -33.3% |
| 2026-03-31 | 2026-05-13 | -0.0486 | 0.0600 | -181.0% |
| 2025-12-31 | 2026-03-19 | 0.2000 | 0.1100 | +81.8% |
| 2025-09-30 | 2025-11-06 | 0.1600 | 0.1000 | +60.0% |
Investor takeaway: The EPS miss was steep, but it doesn’t tell the whole story. Revenue and operating measures also matter. The C$128.4 million net loss makes it worth examining how adjusted operating performance compares with the bottom line. WELL reaffirmed its 2026 adjusted EBITDA guidance, but investors should also assess cash generation, what drove the loss, and whether the company is moving toward sustainable profitability. The earnings trend table and chart compare recent quarters. WELL beat estimates in one of its last four reported quarters.
C$0.50 loss per share versus a C$0.04 loss estimate
WELL’s EPS was C$0.46 below the estimate, an 1,150% miss. The company separately reported C$407.4 million in quarterly revenue and a C$128.4 million net loss attributable to WELL. These figures show different parts of the quarter: revenue growth and higher adjusted EBITDA don’t erase the reported loss.
Bull case
Revenue reached C$407.4 million, with estimated year-over-year growth of 11.7%. Adjusted EBITDA in Canadian Patient Services rose 82% to C$25.7 million. WELL said the segment reached a C$100 million annualized run rate one quarter ahead of plan. The company also reaffirmed its 2026 adjusted EBITDA guidance of C$185 million to C$195 million, giving investors a target to track. The Competition Bureau’s no-action letter resolved its merger review, according to the company announcement.
Bear case
EPS of -C$0.50 fell well short of the -C$0.04 estimate. WELL’s reported C$128.4 million quarterly net loss also shows that stronger adjusted operating results did not prevent a large bottom-line loss. The company beat estimates in only one of its last four comparable quarters and missed in the two quarters before this one. Shares closed at C$3.65, below their 50-day and 200-day moving averages and close to the supplied 52-week low of C$3.54. Investors should review the filings to understand what drove the loss and how adjusted measures compare with reported results.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


